Forum
Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa?
Abstract
Authors' affiliations
Joseph N Jarvis, Infectious Diseases Research Unit, GF Jooste Hospital
Thomas S Harrison, Centre for Infection, Department of Cellular and Molecular Medicine, St. George’s University of London
Nelesh Govender, Mycology Reference Unit, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Stephen D Lawn, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Nicky Longley, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Tihana Bicanic, Centre for Infection, Department of Cellular and Molecular Medicine, St. George’s University of London
Gary Maartens, Division of Clinical Pharmacology, Department of Medicine, University of Cape Town
Francois Venter, Wits Institute for Sexual & Reproductive Health, HIV and Related Diseases and Department of Medicine, University of the Witwatersrand
Linda-Gail Bekker, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Robin Wood, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Graeme Meintjes, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa
Full Text
PDF (94KB)Keywords
Cite this article
Article History
Date published: 2011-04-04
Article Views
Full text views: 1932
Comments on this article
*Read our policy for posting comments here